investorscraft@gmail.com

Intrinsic Value of Albireo Pharma (ALBO)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %388.4NaN
Revenue, $41NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m164NaN
Operating income, $m-123NaN
EBITDA, $m-110NaN
Interest expense (income), $mNaN
Earnings before tax, $m-34NaN
Tax expense, $m0NaN
Net income, $m-34NaN

BALANCE SHEET

Cash and short-term investments, $m248NaN
Total assets, $m302NaN
Adjusted assets (=assets-cash), $m54NaN
Average production assets, $m18NaN
Working capital, $m224NaN
Total debt, $m23NaN
Total liabilities, $m126NaN
Total equity, $m176NaN
Debt-to-equity ratio0.131NaN
Adjusted equity ratio-1.104NaN

CASH FLOW

Net income, $m-34NaN
Depreciation, amort., depletion, $m13NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-108NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-0NaN
Free cash flow, $m-107NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m224
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount